ArticleScientific reports2026
Enhancing polygenic risk prediction by modeling quantile-specific genetic effects.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Polygenic risk scores (PRSs) quantify an individual's genetic susceptibility to complex traits and diseases. Conventional PRSs, which are based on linear models, perform poorly for phenotypes with skewed distributions or with genetic effects that vary across the distribution. We propose a quantile regression-based PRS (QPRS) that can capture quantile-specific genetic effects. While existing PRSs provide only a single score, QPRS models genetic influences at multiple quantiles of the phenotype, thereby enhancing predictive performance by utilizing these multiple scores as covariates. We evaluate the performance of our method through both simulations and a real-data application. In simulations, QPRS significantly reduces the mean squared error compared to the linear-based PRS, both in the presence of variance quantitative trait loci and outliers. For real data analysis, we use data from Korea Genome and Epidemiology Study to evaluate predictive performance. We consider two prediction tasks: continuous outcomes (triglycerides and glucose level) and a binary outcome (diabetes status, derived from glucose level). QPRS demonstrates consistent improvements over conventional mean-based PRSs across both prediction tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.